Xylem (NYSE:XYL) Stock Gets Price Target Cut from Oppenheimer

Xylem (NYSE:XYL) had its price target decreased by research analysts at Oppenheimer from $150.00 to $135.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the industrial products company’s stock. Oppenheimer‘s price target would indicate a potential upside of 44.94% from the company’s current price.

Other research analysts have also recently issued reports about the company. Robert W. Baird lifted their price target on Xylem from $163.00 to $165.00 and gave the company an “outperform” rating in a research report on Wednesday, July 29th. Jefferies Financial Group boosted their target price on shares of Xylem from $145.00 to $150.00 and gave the company a “buy” rating in a research note on Monday, August 24th. Citigroup lowered their price target on shares of Xylem from $172.00 to $148.00 and set a “buy” rating on the stock in a report on Monday, October 12th. Royal Bank Of Canada reissued an “outperform” rating and set a $125.00 target price on shares of Xylem in a research note on Wednesday. Finally, The Goldman Sachs Group restated a “buy” rating and set a $138.00 target price on shares of Xylem in a research report on Wednesday. Nine equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $135.23.

Xylem Trading Down 13.9%

NYSE:XYL opened at $93.14 on Wednesday. The company’s fifty day moving average price is $106.50 and its 200-day moving average price is $118.31. Xylem has a 1-year low of $92.61 and a 1-year high of $154.27.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.45 by ($0.01). The firm had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.28 billion. During the same period in the previous year, the business posted $1.37 earnings per share. The firm’s revenue for the quarter was down 3.0% on a year-over-year basis. On average, equities research analysts anticipate that Xylem will post 5.65 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. William Mack & Associates Inc. purchased a new stake in shares of Xylem in the 3rd quarter valued at approximately $25,000. Dunhill Financial LLC purchased a new position in Xylem in the second quarter valued at $30,000. Avalon Trust Co purchased a new position in shares of Xylem in the 2nd quarter valued at about $35,000. Orion Capital Management LLC acquired a new position in Xylem during the 2nd quarter worth approximately $35,000. Finally, Aventus Investment Advisors Inc. increased its holdings in Xylem by 66.7% in the second quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company’s stock valued at $35,000 after buying an additional 120 shares during the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem News Summary

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Orders increased 10% year over year, indicating continued underlying demand for Xylem’s water and infrastructure solutions despite weaker reported sales. Management also highlighted growth opportunities tied to infrastructure investment and data centers. Xylem Q3 2026 slides: orders surge 10% but guidance cut sends shares lower
• Positive Sentiment: Adjusted third-quarter EPS rose to $1.44 from $1.37 a year earlier, while net income for the first nine months reached $747 million. These results show earnings resilience even as revenue weakened. Xylem Reports $747 Million Net Income for First Nine Months of 2026
• Neutral Sentiment: Xylem plans portfolio divestitures and a segment restructuring. The moves could improve focus and efficiency over time, but they also signal a strategic reset and may create near-term execution and restructuring costs. Xylem cuts 2026 outlook, plans divestitures and segment restructure
• Negative Sentiment: Third-quarter revenue fell 3% year over year to $2.20 billion, approximately $80 million below expectations. EPS of $1.44 also missed consensus, with softer metering demand and project timing weighing on sales. Xylem Stock Price Sinks After Q3 Results Miss Revenue Mark
• Negative Sentiment: Management lowered its 2026 revenue and profit outlook and issued a weak fourth-quarter forecast, reinforcing concerns that customer spending and project activity may remain under pressure. Xylem Stock Plunges to 52-Week Low After Slashing 2026 Profit Outlook
• Negative Sentiment: JPMorgan downgraded Xylem from “overweight” to “neutral” and cut its price target from $118 to $90, adding further pressure to investor sentiment.
• Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to the earnings miss and outlook reduction. The notice does not establish wrongdoing but adds legal and reputational risk. Xylem Inc. Investigation Notice

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.